We discovered that combing CDH1 with miR-340, miR-185, or miR-20a could improve the diagnostic efficiency in BC, with areas under the ROC curve (AUC) of 0.884, 0.702, and 0.74, respectively (Figures 6A–C). Here, CDH1 is linked to breast cancer.